Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Barwick..maybe SGS will swoop in and snap up OO down the line...The model suits them perfectly even the Data division and SGS could add to it..
So maybe 2 Swiss companies will buy out OO's 2 assets..
Hvivo/Venn and Imutex..
And then there's Prepbiopharma
Are you sure he’s left bron, as one of the links posted says different,
£100m mcap
$100?
He left a $20 billion company to work for a $100 company..
Nuff said..
He's just a new hire..He was just having a little fun on Twitter apparently..
CF did say last week he wopnt RNS every bit of news just for the sake of it, we will find out soon how this news ranks in the leauge table of news, GL
Surprised there has not been an RNS
Developing a 'working' version of covid19 is what hVIVO are attempting to do.
Without it, they cannot develop [or sell] a challenge study for covid19.
Adrian Wildfire is yet another specialist in this area.
CF has hired extra talent to achieve this aim while at the same time eliminating all competition.
Also, when i use the word 'hired' i'm using Cathal's phrasing, not mine.
This is an interesting piece on CHIMagents, including this line:
"In London, infectious disease expert Adrian Wildfire — known among colleagues as the "flying virologist" for motorbiking between various pathogen projects in the city — is drawing up plans to manufacture the coronavirus. He's aiming for a Goldilocks virus — not too strong but not too weak to infect most volunteers. He would have to contract with an outside lab to make it, likely a multimillion-dollar endeavor at Biosafety Level 3, the same as rabies and bird flu."
https://www.nbcnews.com/health/health-news/why-have-14-000-people-volunteered-be-infected-coronavirus-n1203931
You don't get much more involved in the pandemic than manufacturing the virus... OO seemingly looking to corner this extraordinary market